Walleye Trading’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-12,812
| Closed | -$380K | – | 5621 |
|
|
2023
Q4 | $380K | Buy |
12,812
+1,565
| +14% | +$31.2K | ﹤0.01% | 3302 |
|
|
2023
Q3 | $178K | Sell |
11,247
-80,619
| -88% | -$1.34M | ﹤0.01% | 3681 |
|
|
2023
Q2 | $1.73M | Buy |
+91,866
| New | +$1.08M | 0.01% | 1762 |
|
|
2022
Q1 | – | Sell |
-72,885
| Closed | -$404K | – | 6055 |
|
|
2021
Q4 | $541K | Buy |
+72,885
| New | +$453K | ﹤0.01% | 2881 |
|
|
2020
Q1 | – | Sell |
-30,553
| Closed | -$156K | – | 4721 |
|
|
2019
Q4 | $156K | Sell |
30,553
-73,614
| -71% | -$250K | ﹤0.01% | 3336 |
|
|
2019
Q3 | $252K | Buy |
104,167
+77,188
| +286% | +$205K | ﹤0.01% | 2751 |
|
|
2019
Q2 | $59K | Buy |
+26,979
| New | +$63.8K | ﹤0.01% | 3487 |
|
|
2019
Q1 | – | Sell |
-7,250
| Closed | -$35K | – | 4928 |
|
|
2018
Q4 | $35K | Buy |
+7,250
| New | +$44K | ﹤0.01% | 4238 |
|
|
2017
Q2 | – | Sell |
-11,000
| Closed | -$43 | – | 5055 |
|
|
2017
Q1 | $43 | Sell |
11,000
-71,000
| -87% | -$207K | ﹤0.01% | 3842 |
|
|
2016
Q4 | $167K | Buy |
82,000
+80,700
| +6,208% | +$162K | ﹤0.01% | 2897 |
|
|
2016
Q3 | $3K | Buy |
+1,300
| New | +$3.78K | ﹤0.01% | 4643 |
|
|
2016
Q1 | – | Sell |
-10,558
| Closed | -$143K | – | 5957 |
|
|
2015
Q4 | $143K | Buy |
10,558
+10,058
| +2,012% | +$124K | ﹤0.01% | 3007 |
|
|
2015
Q3 | $5K | Buy |
500
+300
| +150% | +$4.39K | ﹤0.01% | 4632 |
|
|
2015
Q2 | $3K | Buy |
+200
| New | +$2.2K | ﹤0.01% | 4635 |
|
Other funds holding IMGN
Walleye Trading's IMGN Position: Q1 2024 in Review
Walleye Trading sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 12,812 shares — an estimated $380K sold.
Walleye Trading first reported a position in IMGN in Q2 2015 and held it in 14 quarters. The position peaked at $1.73M in Q2 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- Walleye Trading reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- Walleye Trading sold 12,812 Immunogen Inc shares in Q1 2024, an estimated $380K.
- Walleye Trading first reported a position in Immunogen Inc in Q2 2015 and held it in 14 quarters.
- Walleye Trading's Immunogen Inc position peaked at $1.73M in Q2 2023.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on Walleye Trading's 13F filing for Q1 2024, filed 15 May 2024.